Background: Neuropathic pain (NP) is considered a clinically incurable condition despite various treatment options due to its diverse causes and complicated disease mechanisms. Since the early 2000s, multipotent human mesenchymal stem cells (hMSCs) have been used in the treatment of NP in animal models. However, the effects of hMSC injections have not been studied in chronic post-ischemia pain (CPIP) mice models. Here, we investigated whether intrathecal (IT) and intrapaw (IP) injections of hMSCs can reduce mechanical allodynia in CPIP model mice.
Methods: Seventeen CPIP C57/BL6 mice were selected and randomized into four groups: IT sham (n = 4), IT stem (n = 5), IP sham (n = 4), and IP stem (n = 4). Mice in the IT sham and IT stem groups received an injection of 5 μL saline and 2 × 104 hMSCs, respectively, while mice in the IP sham and IP stem groups received an injection of 5 μL saline and 2 × 105 hMSCs, respectively. Mechanical allodynia was assessed using von Frey filaments from pre-injection to 30 days post-injection. Glial fibrillary acidic protein (GFAP) expression in the spinal cord and dorsal root ganglia were also evaluated.
Results: IT and IP injections of hMSCs improved mechanical allodynia. GFAP expression was decreased on day 25 post-injection compared with the sham group. Injections of hMSCs improved allodynia and GFAP expression was decreased compared with the sham group.
Conclusions: These results suggested that hMSCs may be also another treatment modality in NP model by ischemia-reperfusion.
Keywords: Ganglia; Glial Fibrillary Acidic Protein; Hyperalgesia; Mesenchymal Stromal Cells; Mice; Neuralgia; Reperfusion Injury; Spinal; Spinal Cord; Stem Cells.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Central Administration of Methotrexate Reduces Mechanical Allodynia in an Animal Model of Radiculopathy/SciaticaH Hashizume et al. Pain 87 (2), 159-69. PMID 10924809.We have recently reported that injury to a lumbar root in a rat model of radiculopathy produces spinal glial activation associated with elevated proinflammatory cytokines …
Long-lasting Effects of Human Mesenchymal Stem Cell Systemic Administration on Pain-Like Behaviors, Cellular, and Biomolecular Modifications in Neuropathic MiceD Siniscalco et al. Front Integr Neurosci 5, 79. PMID 22164136.As a potential mechanism of action of hMSCs in reducing pain, we suggest that they could exert their beneficial action through a restorative mechanism involving: (i) a ce …
Astrocyte Contributes to Pain Development via MMP2-JNK1/2 Signaling in a Mouse Model of Complex Regional Pain SyndromeG Tian et al. Life Sci 170, 64-71. PMID 27919822.This study shows that activation of astrocyte MMP2/JNK1/2 signaling pathway contributes to the pathogenesis of pain hypersensitivity in the CPIP model.
The Effects of Generally Administered Anti-Nerve Growth Factor Receptor (p75NTR) Antibody on Pain-Related Behavior, Dorsal Root Ganglia, and Spinal Glia Activation in a Rat Model of Brachial Plexus AvulsionT Kobayashi et al. J Hand Surg Am 40 (10), 2017-25. PMID 26321458.Systemic application of the p75NTR inhibitory antibody suppressed neuropathic pain after BPA.
[Effect of Electroacupuncture on the Expression of Spinal Glial Fibrillary Acidic Protein, Tumor Necrosis Factor-Alpha and interleukin-1beta in Chronic Neuropathic Pain Rats]T Sun et al. Zhen Ci Yan Jiu 35 (1), 12-6. PMID 20458900.EA can effectively suppress CCI-induced up-regulation of expression of spinal GFAP, TNF-alpha mRNA and IL-1beta mRNA, which may contribute to its effect in reducing mecha …